Beauty Farm Medical and Health Industry Inc. (HKG:2373)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.21
-0.30 (-1.71%)
Jun 5, 2026, 4:09 PM HKT

HKG:2373 Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, HKG:2373 stock has a consensus rating of "Strong Buy" and an average price target of $35.25. The average 1-year stock price forecast is 104.82% higher than the current stock price, while the lowest is $29.52 (+71.53%) and the highest is $39.35 (+128.65%).

Price Target: $35.25 (+104.82%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$29.52$35.25$37.94$39.35
Change+71.53%+104.82%+120.45%+128.65%
* Price targets were last updated on Apr 17, 2026.

Analyst Ratings

The average analyst rating for HKG:2373 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy565444
Buy001111
Hold000000
Sell000000
Strong Sell000000
Total566555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
First Shanghai Securities
No rating
First Shanghai Securities
Buy
Maintains
$32.50
BuyMaintains$32.50+88.84%Apr 17, 2026
Unknown Analyst
CGS International
No rating
CGS International
Buy
Maintains
$23.50
BuyMaintains$23.50+36.55%Apr 10, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$42.00$30.00
BuyMaintains$42.00$30.00+74.32%Apr 4, 2026
Unknown Analyst
GF Securities
No rating
GF Securities
Buy
Maintains
$41.12$30.13
BuyMaintains$41.12$30.13+75.07%Apr 1, 2026
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$34.49
BuyMaintains$34.49+100.41%Mar 31, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.99B
from 3.00B
Increased by 32.91%
Revenue Next Year
4.47B
from 3.99B
Increased by 12.09%
EPS This Year
2.05
from 1.64
Increased by 24.83%
EPS Next Year
2.29
from 2.05
Increased by 11.71%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.78B1.64B2.15B2.57B3.00B3.99B
Revenue Growth
18.46%-8.16%31.16%19.91%16.65%32.91%
Gross Profit
833.79M717.84M977.10M1.19B1.47B1.99B
Gross Margin
46.82%43.89%45.55%46.26%49.05%49.83%
Operating Income
257.49M135.73M268.99M309.25M451.78M618.04M
Net Income
193.48M103.11M215.66M228.46M317.56M422.29M
EPS
----1.642.05
EPS Growth
-----24.83%
Forward PE
--7.5013.6616.517.26
Dividend / Share
-0.340.430.490.630.90
Dividend Growth
--23.67%14.54%28.93%42.86%
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High4.0B
Avg4.0B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
34.9%
Avg
32.9%
Low
30.5%

EPS Forecast

EPS202620272028
High2.05
Avg2.05
Low2.05

EPS Growth

EPS Growth202620272028
High
24.8%
Avg
24.8%
Low
24.8%